Our medically guided longevity program uses low-dose tirzepatide to support metabolic health, insulin sensitivity, and appetite regulationwithout aggressive weight loss
Srinivasan, U., Mieyal, P
Personalized Nausea Management Through Genetic Testing The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) variants that relate to GLP-1 and related signaling pathways
As IBD involves oxidative stress and inflammation, these diverse antioxidants collectively act as a shield against cellular damage, offering a multifaceted approach to treatment
The incidence and severity of nausea vary considerably between different GLP-1 preparations and among individual patients
For patients seeking alternatives, PlexusDx also offers oral semaglutide at $289/mo month-to-month, or from $249/mo on the 6-month plan and compounded tirzepatide at $289/mo month-to-month, or from $249/mo on the 6-month plan, providing flexibility within transparent price structures